Novo Nordisk’s investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes–presented at ADA 2026

A phase 2 study of investigational once-weekly subcutaneous zenagamtide showed statistically significant reductions in blood sugar…

Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes

Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More…

The hidden costs of delayed diagnosis and diagnostic ambiguity

One of the most damaging patterns in health care is also one of the most accepted:…

Why the U.S. needs more preventive medicine and public health doctors

“What is that?” I was sitting in the emergency room during my emergency medicine rotation, chatting…

Failing the residency match: What I learned from not matching

It was March 9, 2026. I remember the moment vividly. I woke up with a mix…

Bariatric surgery vs. semaglutides vs. endoscopic visceral lipectomy

Despite the emergence of new pharmacologic alternatives to traditional bariatric surgery, the global obesity epidemic continues…

A physician's journey with a hidden CSF leak and delayed diagnosis

In 2023, I was in a serious motor vehicle collision. The injury that followed, a vertebral…

How corporate health care ruined the medical profession

In the golden days of practicing medicine, the hospitals’ boards were composed of community leaders acting…

4 questions to ask about enterprise AI drug dosing

Artificial intelligence is reshaping how health care organizations support clinicians and, ultimately, how they care for…

Overcoming barriers to holding babies with hypoxic-ischemic encephalopathy during therapeutic cooling

Imagine going to the hospital after nine months of pregnancy expecting to have a perfect birth…